These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16079162)

  • 21. Case-cohort designs and analysis for clustered failure time data.
    Lu SE; Shih JH
    Biometrics; 2006 Dec; 62(4):1138-48. PubMed ID: 17156289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regression analysis of doubly censored failure time data with frailty.
    Kim YJ
    Biometrics; 2006 Jun; 62(2):458-64. PubMed ID: 16918909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of clustered and interval censored data from a community-based study in asthma.
    Bellamy SL; Li Y; Ryan LM; Lipsitz S; Canner MJ; Wright R
    Stat Med; 2004 Dec; 23(23):3607-21. PubMed ID: 15534894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The analysis of placement values for evaluating discriminatory measures.
    Pepe MS; Cai T
    Biometrics; 2004 Jun; 60(2):528-35. PubMed ID: 15180681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ROC analysis for markers with mass at zero.
    Schisterman EF; Reiser B; Faraggi D
    Stat Med; 2006 Feb; 25(4):623-38. PubMed ID: 16345033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parametric conditional frailty models for recurrent cardiovascular events in the lipid study.
    Cui J; Forbes A; Kirby A; Marschner I; Simes J; West M; Tonkin A
    Clin Trials; 2008; 5(6):565-74. PubMed ID: 19029205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ROC graphs for assessing the ability of a diagnostic marker to detect three disease classes with an umbrella ordering.
    Nakas CT; Alonzo TA
    Biometrics; 2007 Jun; 63(2):603-9. PubMed ID: 17688513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Semiparametric transformation models with time-varying coefficients for recurrent and terminal events.
    Zhao X; Zhou J; Sun L
    Biometrics; 2011 Jun; 67(2):404-14. PubMed ID: 20618309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement of cardiovascular risk prediction: time to review current knowledge, debates, and fundamentals on how to assess test characteristics.
    Romanens M; Ackermann F; Spence JD; Darioli R; Rodondi N; Corti R; Noll G; Schwenkglenks M; Pencina M
    Eur J Cardiovasc Prev Rehabil; 2010 Feb; 17(1):18-23. PubMed ID: 19952758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Joint estimation of diagnostic accuracy measures for paired organs--application in ophthalmology.
    de Leon AR; Soo A; Bonzo DC; Rudnisky CJ
    Biom J; 2009 Oct; 51(5):837-50. PubMed ID: 19697307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does high-sensitivity C-reactive protein add prognostic value to the TIMI-Risk Score in individuals with non-ST elevation acute coronary syndromes?
    Correia LC; Lima JC; Rocha MS; D'Oliveira Junior A; Péricles Esteves J
    Clin Chim Acta; 2007 Jan; 375(1-2):124-8. PubMed ID: 16916502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension.
    Patel JV; Lim HS; Varughese GI; Hughes EA; Lip GY
    Ann Med; 2008; 40(3):215-22. PubMed ID: 18382887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimation of time-dependent area under the ROC curve for long-term risk prediction.
    Chambless LE; Diao G
    Stat Med; 2006 Oct; 25(20):3474-86. PubMed ID: 16220486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating markers for selecting a patient's treatment.
    Song X; Pepe MS
    Biometrics; 2004 Dec; 60(4):874-83. PubMed ID: 15606407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-reactive protein predicts future arterial and cardiovascular events in patients with symptomatic peripheral arterial disease.
    Hogh AL; Joensen J; Lindholt JS; Jacobsen MR; Ostergaard L
    Vasc Endovascular Surg; 2008; 42(4):341-7. PubMed ID: 18458051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
    Persson M; Hedblad B; Nelson JJ; Berglund G
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of outcomes in trauma: anatomic or physiologic parameters?
    Guzzo JL; Bochicchio GV; Napolitano LM; Malone DL; Meyer W; Scalea TM
    J Am Coll Surg; 2005 Dec; 201(6):891-7. PubMed ID: 16310692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review and comparison of ROC curve estimators for a time-dependent outcome with marker-dependent censoring.
    Blanche P; Dartigues JF; Jacqmin-Gadda H
    Biom J; 2013 Sep; 55(5):687-704. PubMed ID: 23794418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of C-reactive protein for cardiovascular risk stratification across three age groups in subjects without existing cardiovascular diseases.
    Hamer M; Chida Y; Stamatakis E
    Am J Cardiol; 2009 Aug; 104(4):538-42. PubMed ID: 19660608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combining multiple markers for classification using ROC.
    Ma S; Huang J
    Biometrics; 2007 Sep; 63(3):751-7. PubMed ID: 17825007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.